IMPAX LABS FDA Approval ANDA 084287

ANDA 084287

IMPAX LABS

FDA Drug Application

Application #084287

Application Sponsors

ANDA 084287IMPAX LABS

Marketing Status

Discontinued001

Application Products

001TABLET;BUCCAL, SUBLINGUAL10MG0METHYLTESTOSTERONEMETHYLTESTOSTERONE

FDA Submissions

ORIG1AP1974-07-16
LABELING; LabelingSUPPL58AP1988-07-06
LABELING; LabelingSUPPL59AP1988-10-31
LABELING; LabelingSUPPL60AP1989-05-11
LABELING; LabelingSUPPL61AP1989-07-20
LABELING; LabelingSUPPL62AP1989-11-28
LABELING; LabelingSUPPL63AP1990-01-19
LABELING; LabelingSUPPL64AP1991-07-05
LABELING; LabelingSUPPL65AP1991-10-09
LABELING; LabelingSUPPL66AP1997-10-29

CDER Filings

IMPAX LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 84287
            [companyName] => IMPAX LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHYLTESTOSTERONE","activeIngredients":"METHYLTESTOSTERONE","strength":"10MG","dosageForm":"TABLET;BUCCAL, SUBLINGUAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"METHYLTESTOSTERONE","submission":"METHYLTESTOSTERONE","actionType":"10MG","submissionClassification":"TABLET;BUCCAL, SUBLINGUAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.